Immediate Impact
2 by Nobel laureates 57 standout
Citing Papers
Open-ST: High-resolution spatial transcriptomics in 3D
2024 Standout
Lightweight and drift-free magnetically actuated millirobots via asymmetric laser-induced graphene
2024 Standout
Works of Robert Alter being referenced
A phase 1b trial of the CXCR4 inhibitor mavorixafor and nivolumab in advanced renal cell carcinoma patients with no prior response to nivolumab monotherapy
2021
Randomized double-blind phase II study of maintenance pembrolizumab versus placebo after first-line chemotherapy in patients (pts) with metastatic urothelial cancer (mUC): HCRN GU14-182.
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Robert Alter | 195 | 253 | 124 | 29 | 446 | |
| Marco Iafolla | 172 | 209 | 137 | 37 | 428 | |
| Florian Huemer | 125 | 310 | 111 | 45 | 481 | |
| K. Nathan Sankar | 155 | 247 | 112 | 38 | 462 | |
| Smitha Menon | 125 | 293 | 134 | 17 | 457 | |
| Xiaowei Dang | 162 | 217 | 156 | 32 | 487 | |
| Byung Woog Kang | 192 | 240 | 65 | 21 | 402 | |
| Pritesh Trivedi | 79 | 187 | 136 | 19 | 388 | |
| Guangyu An | 139 | 255 | 105 | 24 | 407 | |
| Xianglei Yan | 100 | 147 | 218 | 23 | 416 | |
| Katrin Bankov | 110 | 176 | 122 | 36 | 441 |
All Works
Loading papers...